Lance Gil

Lance Gil, MBA, is a forward-thinking life sciences and oncology diagnostic executive leader specializing in digital pathology and artificial intelligence. With over 20 years of experience, they have developed molecular laboratories and fostered partnerships within pharma, biotech, and government sectors. Previously, Lance founded National Molecular Laboratories, leading all aspects of the organization from P&L to commercial functions, and achieved significant revenue growth in sales and marketing roles at companies like Aurora Diagnostics and Merck. Currently serving as the National Business Development Director at Quest Diagnostics, Lance continues to innovate in their field while pursuing a Master of Business Administration at Capella University.